$MDBH
MDB Capital Holdings, LLC Stock $mdbh

$mdbh Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224018807 Filed on May 13, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue			$117.0K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin			$2.241M
YoY Change
% of Gross Profit
Research & Development	$237.4K	$277.6K	$31.59K
YoY Change	3037.23%	778.7%
% of Gross Profit
Depreciation & Amortization		$62.79K	$44.12K
YoY Change		42.32%
% of Gross Profit
Operating Expenses	$7.413M	$7.287M	$2.272M
YoY Change	236.9%	220.69%
Operating Profit	-$5.125M	-$660.4K	$117.0K
YoY Change	-189.45%	-664.48%
Interest Expense			$187.3K
YoY Change
% of Operating Profit			160.09%
Other Income/Expense, Net
YoY Change
Pretax Income	-$4.804M	-$7.609M	-$1.968M
YoY Change	-229.35%	286.66%
Income Tax	$2.143K		$0.00
% Of Pretax Income
Net Earnings	-$4.274M	-$7.215M	-$1.968M
YoY Change	-225.97%	266.65%	82.44%
Net Earnings / Revenue			-1682.14%
Basic Earnings Per Share
Diluted Earnings Per Share			-$0.20
COMMON SHARES
Basic Shares Outstanding	4.296M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments			$3.471M
YoY Change
Cash & Equivalents	$17.52M	$5.493M	$3.471M
Short-Term Investments
Other Short-Term Assets	$71.50K		$205.3K
YoY Change	-69.3%
Inventory
Prepaid Expenses
Receivables			$1.013M
Other Receivables			$0.00
Total Short-Term Assets			$4.689M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$910.3K	$946.9K	$1.940M
YoY Change	56.92%	-51.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$16.82M
YoY Change
Other Assets			$595.6K
YoY Change
Total Long-Term Assets	$3.060M	$3.182M	$19.35M
YoY Change	46.6%	-83.56%
TOTAL ASSETS
Total Short-Term Assets			$4.689M
Total Long-Term Assets	$3.060M	$3.182M	$19.35M
Total Assets	$37.71M	$40.94M	$24.04M
YoY Change	37.53%	70.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable			$1.115M
YoY Change
Accrued Expenses			$1.553M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt			$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities			$2.668M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt			$0.00
YoY Change
Other Long-Term Liabilities			$179.6K
YoY Change
Total Long-Term Liabilities			$179.6K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities			$2.668M
Total Long-Term Liabilities			$179.6K
Total Liabilities	$5.150M	$7.416M	$3.276M
YoY Change	86.05%	126.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.58M	-$19.31M
YoY Change	567.12%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$32.98M	$33.77M	$20.77M
YoY Change
Total Liabilities & Shareholders Equity	$37.71M	$40.94M	$24.04M
YoY Change	37.53%	70.28%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$4.274M	-$7.215M	-$1.968M
YoY Change	-225.97%	266.65%	82.44%
Depreciation, Depletion And Amortization		$62.79K	$44.12K
YoY Change		42.32%
Cash From Operating Activities		-$2.259M	-$1.203M
YoY Change		87.86%
INVESTING ACTIVITIES
Capital Expenditures		$143.2K	$6.940K
YoY Change		1962.71%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$3.446M	-$6.940K
YoY Change		-49747.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-$91.51K	-272.3K
YoY Change		-66.4%
NET CHANGE
Cash From Operating Activities		-$2.259M	-1.203M
Cash From Investing Activities		$3.446M	-6.940K
Cash From Financing Activities		-$91.51K	-272.3K
Net Change In Cash		$1.095M	-1.482M
YoY Change		-173.89%
FREE CASH FLOW
Cash From Operating Activities		-$2.259M	-$1.203M
Capital Expenditures		$143.2K	$6.940K
Free Cash Flow		-$2.402M	-$1.210M
YoY Change		98.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001934642
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q4	srt	Payables To Customers PayablesToCustomers		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2023Q1	MDBH	Increase Decrease In Payables To Noncustomers IncreaseDecreaseInPayablesToNoncustomers		usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt		usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt		usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	MDBH	Ownership Change Of Noncontrolling Interest OwnershipChangeOfNoncontrollingInterest		usd
CY2023Q1	MDBH	Deferred Costs Of Initial Public Offering DeferredCostsOfInitialPublicOffering		usd
CY2024Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss		usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss		usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease		usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1		usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1		usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases		usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q1	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2024Q1	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized		usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized		usd
CY2023Q1	MDBH	Grants For Equipment Purchased GrantsForEquipmentPurchased		usd
CY2024Q1	us-gaap	Interest Expense InterestExpense		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41751
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	MDB CAPITAL HOLDINGS, LLC
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-4366624
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	14135 Midway Road
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite G-150
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Addison
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75001
CY2024Q1	dei	City Area Code CityAreaCode	(945)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	262-9010
CY2024Q1	dei	Security12b Title Security12bTitle	Class A Common Shares, representing Limited Liability Interests
CY2024Q1	dei	Trading Symbol TradingSymbol	MDBH
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4295632	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5492612	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6109806	usd
CY2024Q1	us-gaap	Cash And Securities Segregated Under Securities Exchange Commission Regulation CashAndSecuritiesSegregatedUnderSecuritiesExchangeCommissionRegulation	2959994	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Securities Exchange Commission Regulation CashAndSecuritiesSegregatedUnderSecuritiesExchangeCommissionRegulation	1247881	usd
CY2024Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	503777	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	783520	usd
CY2024Q1	us-gaap	Grants Receivable GrantsReceivable	1111611	usd
CY2023Q4	us-gaap	Grants Receivable GrantsReceivable	882319	usd
CY2024Q1	MDBH	Clearing Deposits Current ClearingDepositsCurrent	703740	usd
CY2023Q4	MDBH	Clearing Deposits Current ClearingDepositsCurrent	260000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	494463	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	523788	usd
CY2024Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	21381362	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4999237	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2024Q1	MDBH	Investment Securities At Cost Less Impairment InvestmentSecuritiesAtCostLessImpairment	200000	usd
CY2023Q4	MDBH	Investment Securities At Cost Less Impairment InvestmentSecuritiesAtCostLessImpairment	200000	usd
CY2024Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	266945	usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	69303	usd
CY2024Q1	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	147503	usd
CY2023Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	75328	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	946850	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	866490	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2235559	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2320119	usd
CY2024Q1	us-gaap	Assets Assets	40939876	usd
CY2023Q4	us-gaap	Assets Assets	42985279	usd
CY2024Q1	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	916782	usd
CY2023Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent	578214	usd
CY2024Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	515853	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1105078	usd
CY2024Q1	MDBH	Payables To Noncustomers PayablesToNoncustomers	2374132	usd
CY2023Q4	MDBH	Payables To Noncustomers PayablesToNoncustomers	1405293	usd
CY2024Q1	srt	Payables To Customers PayablesToCustomers	1115663	usd
CY2024Q1	MDBH	Deferred Grant Reimbursement DeferredGrantReimbursement	133909	usd
CY2023Q4	MDBH	Deferred Grant Reimbursement DeferredGrantReimbursement	140703	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2339955	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2415889	usd
CY2024Q1	us-gaap	Liabilities Liabilities	7416294	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5665177	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53075777	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	49405779	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19308352	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12092927	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	33767425	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	37312852	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-243843	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	7250	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33523582	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37320102	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40939876	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42985279	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-747268	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	54779	usd
CY2024Q1	us-gaap	Other Operating Income OtherOperatingIncome	86879	usd
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	62212	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-660389	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	116991	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4892675	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	872027	usd
CY2024Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	320292	usd
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	301702	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	919089	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	604662	usd
CY2024Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	205991	usd
CY2023Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	147407	usd
CY2024Q1	MDBH	Clearing And Other Charges ClearingAndOtherCharges	2036	usd
CY2023Q1	MDBH	Clearing And Other Charges ClearingAndOtherCharges	10754	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	669126	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	304079	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7009209	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2240631	usd
CY2024Q1	MDBH	Research And Development Grants ResearchAndDevelopmentGrants	708700	usd
CY2023Q1	MDBH	Research And Development Grants ResearchAndDevelopmentGrants	793540	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	277582	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31592	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	7286791	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2272223	usd
CY2024Q1	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-7947180	usd
CY2023Q1	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-2155232	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	337852	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	187291	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7609328	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1967941	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-7609328	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1967941	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-393903	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-94193	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-7215425	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1873748	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	37320102	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3812808	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-7609328	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33523582	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23109008	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23109008	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54126	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1967941	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21195193	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21195193	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-7609328	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1967941	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-747268	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	54779	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3812809	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54126	usd
CY2024Q1	MDBH	Accretion Of Investments At Amortized Cost Us Treasury Bills AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills	305047	usd
CY2023Q1	MDBH	Accretion Of Investments At Amortized Cost Us Treasury Bills AccretionOfInvestmentsAtAmortizedCostUSTreasuryBills	187291	usd
CY2024Q1	MDBH	Proceeds From Sale Of Investment Securities At Fair Value ProceedsFromSaleOfInvestmentSecuritiesAtFairValue	25129	usd
CY2023Q1	MDBH	Proceeds From Sale Of Investment Securities At Fair Value ProceedsFromSaleOfInvestmentSecuritiesAtFairValue	776281	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	62792	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44124	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	72175	usd
CY2024Q1	MDBH	Accretion Of Deferred Grant Reimbursement AccretionOfDeferredGrantReimbursement	-13173	usd
CY2023Q1	MDBH	Accretion Of Deferred Grant Reimbursement AccretionOfDeferredGrantReimbursement	12960	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	84560	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	57070	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-75934	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-19286	usd
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	229292	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	203122	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	76810	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-39788	usd
CY2024Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	443740	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	338567	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	399405	usd
CY2024Q1	MDBH	Increase Decrease In Payables To Noncustomers IncreaseDecreaseInPayablesToNoncustomers	-1212595	usd
CY2024Q1	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers	871907	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-589225	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-105527	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2259097	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1154192	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	12066207	usd
CY2024Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	8483911	usd
CY2024Q1	MDBH	Proceeds Of Deferred Grant Reimbursement ProceedsOfDeferredGrantReimbursement	6379	usd
CY2023Q1	MDBH	Proceeds Of Deferred Grant Reimbursement ProceedsOfDeferredGrantReimbursement	-48375	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	143152	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6942	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3445523	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55317	usd
CY2024Q1	MDBH	Payment Of Deferred Costs Of Initial Public Offering PaymentOfDeferredCostsOfInitialPublicOffering	91507	usd
CY2023Q1	MDBH	Payment Of Deferred Costs Of Initial Public Offering PaymentOfDeferredCostsOfInitialPublicOffering	272322	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-91507	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-272322	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1094919	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1481831	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7357687	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4952624	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8452606	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3470793	usd
CY2023Q1	MDBH	Ownership Change Of Noncontrolling Interest OwnershipChangeOfNoncontrollingInterest	-153044	usd
CY2024Q1	MDBH	Deferred Costs Of Initial Public Offering DeferredCostsOfInitialPublicOffering	-106135	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5492612	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6109806	usd
CY2024Q1	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	2959994	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	1247881	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8452606	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7357687	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zUoifkgDnFVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z6Pl7Sh1t3W8">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period, as well as the disclosure of contingent assets and liabilities. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in the valuation of investment securities, valuing equity instruments issued for services, stock-based compensation and the realization of any deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	MDBH	Cash Sipc Insured Amount CashSIPCInsuredAmount	500000	usd
CY2024Q1	us-gaap	Cash And Securities Segregated Under Federal And Other Regulations CashAndSecuritiesSegregatedUnderFederalAndOtherRegulations	2959994	usd
CY2023Q4	us-gaap	Cash And Securities Segregated Under Securities Exchange Commission Regulation CashAndSecuritiesSegregatedUnderSecuritiesExchangeCommissionRegulation	1247881	usd
CY2024Q1	MDBH	Clearing Deposits Current ClearingDepositsCurrent	703740	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	494463	usd
CY2024Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	43500	usd
CY2024Q1	MDBH	Prepaid Professional Fees PrepaidProfessionalFees	50000	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	47380	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	312531	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	41052	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	523788	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	43500	usd
CY2023	MDBH	Prepaid Professional Fees PrepaidProfessionalFees	95000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	47380	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	325777	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	12131	usd
CY2024Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	21381362	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4999237	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2024Q1	MDBH	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2023Q4	MDBH	Investment Securities At Cost Less Impairment Non Broker Dealer InvestmentSecuritiesAtCostLessImpairmentNonBrokerDealer	200000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-747268	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	54779	usd
CY2024Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	21381362	usd
CY2024Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	1035	usd
CY2024Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	21382397	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	24658611	usd
CY2023Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	6031	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	24664642	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4999237	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2024Q1	MDBH	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-540912	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	2592546	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	2592546	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5771634	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease	2645620	usd
CY2023	MDBH	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	652925	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	165087	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3133458	usd
CY2024Q1	MDBH	Grant Fees GrantFees	28163	usd
CY2023Q1	MDBH	Grant Fees GrantFees	26673	usd
CY2024Q1	MDBH	Grant Funds Received GrantFundsReceived	-479408	usd
CY2023Q1	MDBH	Grant Funds Received GrantFundsReceived	-590418	usd
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	809532	usd
CY2024Q1	MDBH	Grant Costs Expensed GrantCostsExpensed	674158	usd
CY2023Q1	MDBH	Grant Costs Expensed GrantCostsExpensed	766867	usd
CY2024Q1	MDBH	Grants For Equipment Purchased GrantsForEquipmentPurchased	6379	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1470961	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1327809	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	524111	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	461319	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	946850	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	866490	usd
	MDBH	Contract With Customer Liability Amounts Billed Not Recognized ContractWithCustomerLiabilityAmountsBilledNotRecognized	100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	80000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20000	usd
CY2023Q4	us-gaap	Grants Receivable GrantsReceivable	882319	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3186609	usd
CY2023Q4	us-gaap	Assets Assets	42985279	usd
CY2024Q1	us-gaap	Grants Receivable GrantsReceivable	1111611	usd
CY2023Q1	us-gaap	Grants Receivable GrantsReceivable	1012654	usd
CY2024Q1	MDBH	Grant Costs Expensed GrantCostsExpensed	674158	usd
CY2023Q1	MDBH	Grant Costs Expensed GrantCostsExpensed	766867	usd
CY2024Q1	MDBH	Grant Drawdowns GrantDrawdowns	708700	usd
CY2023Q1	MDBH	Grant Drawdowns GrantDrawdowns	793540	usd
CY2024Q1	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	986282	usd
CY2023Q1	MDBH	Research And Development Expense Gross ResearchAndDevelopmentExpenseGross	825132	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	73297	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	34420	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	3182409	usd
CY2024Q1	us-gaap	Assets Assets	40939876	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-747268	usd
CY2024Q1	us-gaap	Other Operating Income OtherOperatingIncome	86879	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-660389	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	4892675	usd
CY2024Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	320292	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	919089	usd
CY2024Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	205991	usd
CY2024Q1	MDBH	Clearing And Other Charges ClearingAndOtherCharges	2036	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	669126	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7009209	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	277582	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	7286791	usd
CY2024Q1	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-7947180	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	337852	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7609328	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-7609328	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-393903	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-7215425	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	54779	usd
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	62212	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	116991	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	872027	usd
CY2023Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	301702	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	604662	usd
CY2023Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	147407	usd
CY2023Q1	MDBH	Clearing And Other Charges ClearingAndOtherCharges	10754	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	304079	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2240631	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31592	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2272223	usd
CY2023Q1	MDBH	Net Operating Income Loss NetOperatingIncomeLoss	-2155232	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	187291	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1967941	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1967941	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1967941	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-94193	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1873748	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1067356	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.22
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M29D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1067356	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.22
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M29D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1018012	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.66
	MDBH	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2085368	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.43
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M19D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	311636	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.66
CY2024Q1	MDBH	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P7Y
CY2023Q4	MDBH	Annual Operating Cost Increase Percentage AnnualOperatingCostIncreasePercentage	0.030	pure
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P91M
CY2022Q3	us-gaap	Advance Rent AdvanceRent	12556	usd
CY2022Q3	MDBH	Base Rent BaseRent	13937	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2235559	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2320119	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2339955	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2415889	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2397004	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.46
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	462518	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.22
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y9M29D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	695035	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.46
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M18D
CY2024Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	320792	usd
CY2023Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	301702	usd
CY2024Q1	srt	Net Capital NetCapital	6035959	usd
CY2023Q1	srt	Net Capital NetCapital	2284695	usd
CY2024Q1	srt	Minimum Net Capital Required1 MinimumNetCapitalRequired1	6175623	usd
CY2024Q1	us-gaap	Other Commitments Description OtherCommitmentsDescription	0.98 to 1
CY2024Q1	us-gaap	Ratio Of Indebtedness To Net Capital1 RatioOfIndebtednessToNetCapital1	0.02	pure
CY2024Q1	srt	Minimum Net Capital Required For Entity1 MinimumNetCapitalRequiredForEntity1	0	usd
CY2024Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	189365	usd
CY2023Q1	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	163027	usd
CY2024Q1	MDBH	Payment For Licensed Products PaymentForLicensedProducts	250000	usd
CY2024Q1	MDBH	Cumulative Net Sales CumulativeNetSales	1000000	usd
CY2023Q2	us-gaap	Advance Rent AdvanceRent	14371	usd
CY2023Q2	MDBH	Base Rent BaseRent	16747	usd
CY2023Q2	MDBH	Annual Operating Cost Increase Percentage AnnualOperatingCostIncreasePercentage	0.025	pure
CY2023Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P12M
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P60M
CY2023Q4	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	option to extend for 60 additional months
CY2023Q4	us-gaap	Advance Rent AdvanceRent	13277	usd
CY2023Q4	MDBH	Base Rent BaseRent	15391	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M7D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y3M29D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0766	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0740	pure
CY2024Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	121688	usd
CY2023	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	206837	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1018002	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	45754	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	146836	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	84560	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	275589	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	130314	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	422425	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	369936	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	503684	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	516001	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	528586	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	541674	usd
CY2024Q1	MDBH	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	451600	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2911481	usd
CY2024Q1	MDBH	Less Effects Of Discounting LessEffectsOfDiscounting	-571526	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2339955	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.27	pure

Files In Submission

Name	View Source	Status
0001493152-24-018807-index-headers.html	Edgar Link	pending
0001493152-24-018807-index.html	Edgar Link	pending
0001493152-24-018807.txt	Edgar Link	pending
0001493152-24-018807-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
mdbh-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
mdbh-20240331_cal.xml	Edgar Link	unprocessable
mdbh-20240331_lab.xml	Edgar Link	unprocessable
mdbh-20240331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mdbh-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDBH
MDB Capital Holdings, LLC Stock $mdbh

2024 Q2 Form 10-Q Financial Statement

#000149315224018807 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDBH MDB Capital Holdings, LLC Stock $mdbh

2024 Q2 Form 10-Q Financial Statement

#000149315224018807 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDBH
MDB Capital Holdings, LLC Stock $mdbh